Colorectal Cancer Clinical Trials in Boston

Showing 121-134 of 134 trials

Educational CD-ROM Compared With Standard Informed Consent for Patients With Colorectal Cancer or a Family History of Colorectal Cancer

NCT00450424

RATIONALE: The use of a CD-ROM may help patients with colorectal cancer or a family history of colorectal cancer make informed decisions about undergoing microsatellite instability (MSI) testing. PURPOSE: This randomized clinical trial is studying an educational CD-ROM to see how well it works compared with standard informed consent to assist decision-making about MSI testing in patients with colorectal cancer or a family history of colorectal cancer.

Colorectal CancerHereditary Non-polyposis Colon Cancer

Fox Chase Cancer Center239 participantsStarted Jun 2007

Newark, Delaware, United States • Boston, Massachusetts, United States • Philadelphia, Pennsylvania, United States

COMPLETEDPHASE3< 1 mile

Educational Intervention With or Without Telephone Counseling in Increasing Colorectal Cancer Screening Compliance in Brothers and Sisters of Patients With Colorectal Cancer

NCT00352638

RATIONALE: Printed educational materials and counseling by telephone may improve colorectal cancer screening compliance in brothers and sisters of patients with colorectal cancer. PURPOSE: This randomized phase III trial is studying standard or personalized printed educational materials with or without telephone counseling to compare how well they work in increasing colorectal cancer screening compliance in brothers and sisters of patients with colorectal cancer.

Colorectal Cancer

Fox Chase Cancer Center660 participantsStarted Aug 2005

Newark, Delaware, United States • Washington D.C., District of Columbia, United States • Tampa, Florida, United States +15 more locations

Educational CD-ROM Compared With Standard Informed Consent for Patients With Colorectal Cancer or a Family History of Colorectal Cancer

Educational Intervention With or Without Telephone Counseling in Increasing Colorectal Cancer Screening Compliance in Brothers and Sisters of Patients With Colorectal Cancer

Colorectal Cancer Trials in Other Cities

Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer

FR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal Cancer

Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal Cancer

ZD 1839 Plus Combination Chemotherapy in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Colorectal Cancer

Computerized Tomographic Colonography Compared With Standard Diagnostic Procedures in Detecting Colorectal Neoplasia

SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to Fluorouracil

Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers

Improving Followup of Abnormal Colon Cancer Screening Tests

Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer

GM-CT-01 Plus 5-Fluorouracil as Third- or Fourth-Line Therapy for Metastatic Colorectal Cancer

Monoclonal Antibody F19 in Treating Patients With Advanced or Metastatic Cancer

Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer

Other Conditions in Boston